Not for use with other long-acting β 2-agonists. Do not exceed recommended dose. Prescribe a short-acting, inhaled β 2-agonist for acute symptoms; monitor for increased need. Monitor for signs ...
Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US ... not adequately controlled on low or medium dose inhaled corticosteroids.